Jun 222016
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – IFM Therapeutics, a biopharmaceutical company developing a portfolio of first-in-class small molecules targeting the innate immune system, today announced the closing of a $27 million Series A financing led by Atlas Venture and Abingworth, with participation from Novartis.… => Read more

IFM Therapeutics adds Jean-François Formela and Vincent Miles to Board along with raising $27m Series A Financing led by Atlas Venture and Abingworth

From:: IFM Therapeutics adds Jean-François Formela and Vincent Miles to Board along with raising $27m Series A Financing led by Atlas Venture and Abingworth

 Posted by at 4:48 pm

Sorry, the comment form is closed at this time.

%d bloggers like this: